Solution structure and functional studies of the highly potent equine antimicrobial peptide DEFA1.

This research focuses on understanding the structure and function of an equine antimicrobial peptide, DEFA1, which is known for its potent activity against a broad range of horse pathogens.

Understanding DEFA1

• The research revolves around the study of Defensins, which are small molecules responsible for the innate immune system in all organisms, including plants and animals.
• Defensins are known to possess antimicrobial activity, and they have the ability to fight a wide variety of microbes, such as bacteria, fungi and viruses, essentially functioning as internal antibiotics.
• A particular subfamily of the defensin family, known as α-Defensins, has its expression limited to specific tissues only.

Role of Equine DEFA1

• The study specifically focuses on Equine DEFA1, an enteric α-defensin, which is secreted exclusively by a type of small intestinal cell called Paneth cells.
• DEFA1 is known for its capability to act against a wide spectrum of microbes, particularly the pathogens known to affect horses such as Rhodococcus equi, various strains of streptococci, Salmonella choleraesuis, and Pasteurella multocida.

NMR-spectroscopy and Functional Studies

• Through Nuclear Magnetic Resonance (NMR) spectroscopy, the researchers were able to solve the three-dimensional structure of DEFA1, providing crucial insight into its configuration and working mechanisms.
• Further, the study successfully demonstrates DEFA1’s specific functionality of aggregating various phospholipids, adding to the understanding of this antimicrobial peptide’s action.